| Kaiser, Dirk (CytoTools 201404 Managing Director) |
Board member, executive |
CytoTools (Group) |
Germany |
| Kaiser, Heinz (Schott 201906 Board Member responsible for diagnostics business) |
Board member, executive |
Schott (Group) |
Germany |
| Kanter, Ulrich (Tecan 201407– Board Member + Head Development + Operations division before Roche Diagnostics) |
Board member, executive |
Tecan (Group) |
Switzerland |
| Kimura, Keiji (Sony 201109 EVP + Executive Officer Sony Corp) |
Board member, executive |
Sony (Group) |
Japan |
| Knowles, Jonathan (Adaptimmune 201311– Executive Board Chairman before non-exec Director + Roche Head Global Research) |
Board member, executive |
Roche (Group) |
Switzerland |
| Kolb, Jürgen (Priaxon AG 200903 Executive Director) |
Board member, executive |
Priaxon AG |
Germany |
| Kröger, René M. (ScheBo Biotech 201102 Executive Director) |
Board member, executive |
ScheBo Biotech (Group) |
Germany |
| Köckler, Jochen (Deutsche Messe AG 201410 Member of Management Board) |
Board member, executive |
Deutsche Messe AG |
Germany |
| Lang, Steffen (Novartis 201803 Global Head Technical Operations joined 1994) |
Board member, executive |
Novartis (Group) |
Switzerland |
| Lee-Chin, Michael (Portland Holdings 202106 Chairman + Founder) |
Board member, executive |
Portland Holdings |
|
| Lemaître, Marc (Solvay 201108 Executive Board Director) |
Board member, executive |
Solvay (Group) |
Germany |
| Ludwig, Jutta (Eckert & Ziegler 202305 Management Board Member) |
Board member, executive |
Eckert & Ziegler (Group) |
Germany |
| Malik, Kemal (Bayer 201402– Executive Board Member for Innovation joined Bayer 1995 before BMS UK) |
Board member, executive |
Bayer (Group) |
Germany |
| McGettrick, Aileen (Psyros Diagnostics 202201 Director + Co-Founder before Novartis NPTU/Vivacta) |
Board member, executive |
Prolight Diagnostics (Group) |
United Kingdom (GB) |
| Merkle, Fritz (OHB-System 200902 Executive Board Director) |
Board member, executive |
Fuchs (Group) |
Germany |
| Mothes, Harald (Solvay 201108 Executive Board Director) |
Board member, executive |
Solvay (Group) |
Germany |
| Noack, Achim (Bayer 201101 Member Board of Management of Bayer CropScience) |
Board member, executive |
Bayer (Group) |
Germany |
| Northoff, Stefan (TeutoCell 201105 Executive Board Member) |
Board member, executive |
Xell AG |
Germany |
| Page, Mark (HH2E 202206 Board Member + Co-Founder) |
Board member, executive |
HH2E (Group) |
Germany |
| Plischke, Wolfgang (Bayer 1980–201404 Executive Board Member for Innovation RETIRED 4/14) |
Board member, executive |
Bayer (Group) |
|
| Pohl, Thomas (GATC 200804 Executive Boad Director) |
Board member, executive |
Eurofins (Group) |
Germany |
| Reckmann, Bernd (Merck KGaA 1986–201604 Executive Board Member since 2007 RETIRED 4/16)) |
Board member, executive |
Merck (DE) (Group) |
Germany |
| Roth, Christine (Bayer 202203– Head Oncology Strategic Business Unit at Pharma Div before GSK + Novartis + BMS) |
Board member, executive |
Bayer (Group) |
Germany |
| Röhm, Robin (JRM Genomics 201806– Director) |
Board member, executive |
JRM Genomics Ltd. (Janus Genomics) |
United Kingdom (GB) |
| Sadeh, Mohammad Javad (JRM Genomics 201806– Director) |
Board member, executive |
JRM Genomics Ltd. (Janus Genomics) |
United Kingdom (GB) |
| Scheefers, Hans (ScheBo Biotech 201102 Executive Director) |
Board member, executive |
ScheBo Biotech (Group) |
Germany |
| Scheefers-Borchel, Ursula (ScheBo Biotech 201102 Executive Director) |
Board member, executive |
ScheBo Biotech (Group) |
Germany |
| Schierenbeck, Andreas (HH2E 202206 Board Member + Co-Founder) |
Board member, executive |
HH2E (Group) |
Germany |
| Schlenk, Michael (Curasan 201410– Executive Board Director before Centogene + ProBioGen) |
Board member, executive |
Curasan AG |
Germany |
| Sen, Michael (Siemens 201711 Manamgent Board Member) |
Board member, executive |
Siemens (Group) |
Germany |
| Sikka, Vishal (SAP 201206 Executive Board Member) |
Board member, executive |
SAP (Group) |
Germany |
| Stars, Hauke (Deutsche Börse 201611 Executive Board Member for Cash Market + Pre-IPO + Growth Financing) |
Board member, executive |
Deutsche Börse (Group) |
Germany |
| Stölting, Michael (Nordrhein-Westfalen (govt) 202012 Management Board Member of NRW.Bank) |
Board member, executive |
Nordrhein-Westfalen (govt region) |
Germany |
| Traeger, Stefan (Tecan 201307–201706 Head of Life Sciences before Leica Microsystems + Zeiss LEAVES 2017) |
Board member, executive |
Tecan (Group) |
Switzerland |
| van Rietschoten, Constantin (Medios 202405– Exec Board Member for International Markets joined 4/23 as Head Intl BusDev) |
Board member, executive |
Medios (DE) (Group) |
Germany |
| Vielsack, Claus (Stratec 201402– Executive Management Board Member for Product Development joined 1998) |
Board member, executive |
Stratec (Group) |
Germany |
| Voigt, Alexander (HH2E 202206 Board Member + Co-Founder) |
Board member, executive |
HH2E (Group) |
Germany |
| von Dalwigk, Reinhard (Analyticon Biotechnologies 201105 Executive Board Chairman) |
Board member, executive |
Analyticon Biotechnologies AG |
Germany |
| Wall, Brian (Calibre Scientific 202303 Executive Chair + Founder plus CEO + Founder of StoneCalibre) |
Board member, executive |
Calibre Scientific (Group) |
United States (USA) |
| Weber, Tim O. (Parter Capital 201411 Board Chairman) |
Board member, executive |
Parter Capital Group AG |
Switzerland |
| Werner, Birgit (UgiSense AG 201604– Exec Board Member) |
Board member, executive |
UgiSense AG |
Germany |
| Wohlhauser, Patrik (Evonik 201201 Executive Board Director) |
Board member, executive |
Evonik (Group) |
Germany |
| Woolfson, Adrian (Replay 202208 Executive Chair + Co-Founder before Sangamo + Nouscom + Pfizer + BMS) |
Board member, executive |
Replay (Group) |
United States (USA) |
| Wyss, André (Novartis –201803 President Novartis Operations LEFT 4/18) |
Board member, executive |
Novartis (Group) |
Switzerland |
| Yadegardjam, Farsin (EVP Capital 201106 Executive Board Director) |
Board member, executive |
EVP Capital Management AG |
Germany |
| Yang, Patrick (National Resilience 202106 Exec Vice Chairman + Board Member at Antheia formerly Roche/Genentech) |
Board member, executive |
National Resilience (Group) |
United States (USA) |
| Yeager, Frank (Eckert & Ziegler 202305– promoted to Management Board Director for Isotope Products) |
Board member, executive |
Eckert & Ziegler (Group) |
Germany |
| Zehntner, Heiner (Endress+Hauser 201309 Member of Executive Board) |
Board member, executive |
Endress+Hauser (Group) |
Switzerland |
| Zucker, Maximilian (Numares 201702 Executive Board Member + Head RnD) |
Board member, executive |
Numares (Group) |
Germany |
| Zöchbauer, Emmerich (BIA Separations 201509 Chair Board of BIA Separations Austria) |
Board member, executive |
Sartorius (Group) |
Austria |
| Ebeling, Thomas (UBS 201711 Standing Member of UBS Oncology Impact Fund former Novartis Pharma CEO) |
Board member (all kinds of boards: supervisory, advisory, management etc.) |
UBS (Group) |
United Kingdom (GB) |
| Hogan, Simon (HydrogenOne 202205 Chairman) |
Board member (all kinds of boards: supervisory, advisory, management etc.) |
Foresight Group (Group) |
United Kingdom (GB) |
| Peacock, Jonathan M. (Jon) (Arix Bioscience 201805 Chairman before Amgen + Novartis Pharmaceuticals AG CFO + McKinsey) |
Board member (all kinds of boards: supervisory, advisory, management etc.) |
Amgen (Group) |
United States (USA) |
| Schupfer, Philipp (Invest AG 202311 Board Member) |
Board member (all kinds of boards: supervisory, advisory, management etc.) |
Invest Unternehmensbeteiligungs AG |
Austria |
| Topen, Andrew (EuropaBio 202009– Chairman main org Novartis before Pfizer + GSK) |
Board member (all kinds of boards: supervisory, advisory, management etc.) |
EuropaBio aisbl – the European Association of Bioindustries |
Belgium |
| Venturi, Miro (Novigenix 202211 Board Director) |
Board member (all kinds of boards: supervisory, advisory, management etc.) |
Novigenix S.A. |
Switzerland |
| Alt, Eckhard (InGeneron 201710 Board Chairman) |
Board member |
InGeneron (Group) |
Germany |
| Barner, Andreas (Boehringer) |
Board member |
Boehringer Ingelheim (Group) |
Germany |
| Baule, Rainer (Fresenius 201004 Board Member) |
Board member |
Fresenius (Group) |
Germany |
| Bizzari, Jean-Pierre (Nordic Nanovector 201605– Board Memeber before Celgene + Sanofi-Aventis) |
Board member |
Nordic Nanovector (Group) |
Norway |
| Eletr, Sam (Third Wave Technologies 200504 Director) |
Board member |
Hologic (Group) |
United States (USA) |
| Fischer, Heinrich (Tecan 200702– Board Member before Saurer) |
Board member |
Tecan (Group) |
Switzerland |
| Georgieva, Svetoslava (EU (govt) 202309 Board Chair of EIC Fund) |
Board member |
EU (govt) |
EU (European Union) |
| Guo, Jianxin (Sinopharm 201704 Chairman) |
Board member |
Sinopharm (China National Pharmaceutical) (Group) |
China |
| Hoogstraate, Janet (NorthX Biologics 202307– before Valneva Sweden AB) |
Board member |
NorthX Biologics Matfors AB |
Sweden |
| Karsdal, Morten Asser (Nordic Bioscience 201706 Board Chairman of KeyBioscience AG) |
Board member |
CCBR (Group) |
Denmark |
| Kleemann, Axel (Asta Medica 1987–2000 before Degussa ua) |
Board member |
Æterna Zentaris (Group) |
Germany |
| Krammer, Alfred (Nanostart AG 200505 Supervisory Board) |
Board member |
BF Holding (Group) |
Germany |
| Kuchejda, Mathis (SPECTARIS 201605 Chairman) |
Board member |
SPECTARIS – Deutscher Industrieverband für optische, medizinische und mechatronische Technologien e. V. |
Germany |
| Madaus, Martin D. (Carlyle Group 202003 Operating Executive before Ortho CDx + Quanterix + Millipore + Roche Dx NA) |
Board member |
Carlyle (Group) |
United States (USA) |
| Marguerre, Wolfgang (Octapharma 201209 Chairman + Founder) |
Board member |
Octapharma (Group) |
Switzerland |
| Matthews, Keith, Chief (ICIF 202203 Chairman) |
Board member |
Indigenous Critical Infrastructure Fund Canada (ICIF) |
Canada |
| Mauvernay, Thierry (Debiopharm 201306 Board Member) |
Board member |
Debiopharm (Group) |
Switzerland |
| McLaren, John (Dinaqor 202009– Chairman of Dynacor Ltd former British diplomat, investment banker + venture capitalist) |
Board member |
Dinaqor (Group) |
United Kingdom (GB) |
| Meier, Roger (Versameb 201812 Board Chairman) |
Board member |
Versameb AG |
Switzerland |
| Meier, Ulf (Niedersachsen (govt) 2023202 Board Member at NBank) |
Board member |
Niedersachsen (govt region) |
Germany |
| Moll, Fred (Ciruit Therapeutics 201312 Chairman) |
Board member |
Circuit Therapeutics Inc. |
United States (USA) |
| Niebel, Volker (Sartorius 201012 Board Member of Sartorius Stedim Biotech) |
Board member |
Sartorius (Group) |
Germany |
| Paulsen, Frederik (Ferring 201911 Chairman) |
Board member |
Ferring (Paulsen Foundation) (Group) |
Switzerland |
| Poandl, Josef (Nuvonis Technologies 201803 Chairman) |
Board member |
Nuvonis Technologies GmbH |
Austria |
| Poonawalla, Cyrus (Poonawalla Group 201307 Chairman + Founder) |
Board member |
Poonawalla (Group) |
India |
| Rathi, V. L. (Advanced Enzyme Technologies 201707 Chairman) |
Board member |
Advanced Enzyme Technologies (Advanced Enzymes) (Group) |
India |
| Tannenbaum, Renee P. (Nordic Nanovector 201605– Board Member before AbbVie + Èlan + Novartis + BMS) |
Board member |
Nordic Nanovector (Group) |
Norway |
| Tsaioun, Katya (Akttyva Therapeutics 202302 Co-Founder + Board Member) |
Board member |
Akttyva Therapeutics Inc. |
United States (USA) |
| Turgut, Kaya (Turgut Ilaç 201511 Board Chairman + Founder) |
Board member |
Turgut Ilaçlari A.S. |
Turkey |
| Wild, Hans-Peter (Wild Group 201509 Owner + Chairman) |
Board member |
Wild Group (Group) |
|
| Wilden, Peter (PolyPeptide 202304 Executive Chair) |
Board member |
PolyPeptide (Group) |
Switzerland |
| Zambon, Elena (Zambon 201907 President) |
Board member |
Zambon (Group) |
Italy |
| Åström, Håkan |
Board member |
Affibody Medical AB |
Sweden |
| Bergau, Torsten (Frankus Rechtsanwälte 202106) |
Attorney / Lawyer |
Frankus Rechtsanwälte |
Germany |
| Braun, Julia (Baker McKenzie 202205) |
Attorney / Lawyer |
Baker McKenzie LLP |
United States (USA) |
| Eschenfelder, Christina (Rittershaus 201511 Lawyer) |
Attorney / Lawyer |
Rittershaus Rechtsanwälte Partnerschaftsgesellschaft mbH |
Germany |
| Eyber, Klaus U. (Kaye Scholer 200407– Attorney + Partner at Kay Scholer in Ffm before Haarmann Hemmelrath) |
Attorney / Lawyer |
Arnold & Porter LLP |
Germany |
| Freier, Gottfried W. (Kaye Scholer LLP 200809 Frankfurt/M) |
Attorney / Lawyer |
Arnold & Porter LLP |
Germany |
| Freudenberg, Rainer (CMS 201408 Associate at CMS Hasche Sigle Ffm) |
Attorney / Lawyer |
CMS (Group) |
Germany |
| Gericke, Dieter (Homburger 201512 Partner Corporate & M&A) |
Attorney / Lawyer |
Homburger AG |
Switzerland |
| Hettich, Christof (Kanzlei Rittershaus + Dievini Hopp) |
Attorney / Lawyer |
Rittershaus Rechtsanwälte Partnerschaftsgesellschaft mbH |
Germany |
| Heukamp, Wessel (Freshfields Bruckhaus Deringer 201610) |
Attorney / Lawyer |
Freshfields (Group) |
United Kingdom (GB) |
| Hirsch, Hendrik (CMS 201408 Partner at CMS Hasche Sigle Ffm) |
Attorney / Lawyer |
CMS (Group) |
Germany |
| Hirse, Thomas (CMS Hasche Sigle 2007 Attorney at CMS Hasche Sigle Düsseldorf before Linklaters LLP Köln) |
Attorney / Lawyer |
CMS (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 89 90 91 
Position
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
